In this episode of The SHEA Podcast, host Dr. Jonathan Ryder (University of Nebraska Medical Center) speaks with Dr. Aditi Ramakrishnan (Washington University in St. Louis) about how antimicrobial stewardship programs can play a vital role in managing and preventing resistant sexually transmitted infections. They explore the challenges and opportunities at this intersection — from the promise and controversy surrounding doxycycline post-exposure prophylaxis (DoxyPEP), to the debate over routine STI screening among populations on PrEP, and the broader stewardship considerations beyond antibiotic use.
All content for The SHEA Podcast is the property of The SHEA Podcast and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode of The SHEA Podcast, host Dr. Jonathan Ryder (University of Nebraska Medical Center) speaks with Dr. Aditi Ramakrishnan (Washington University in St. Louis) about how antimicrobial stewardship programs can play a vital role in managing and preventing resistant sexually transmitted infections. They explore the challenges and opportunities at this intersection — from the promise and controversy surrounding doxycycline post-exposure prophylaxis (DoxyPEP), to the debate over routine STI screening among populations on PrEP, and the broader stewardship considerations beyond antibiotic use.
Host Dr. Jonathan Ryder speaks with Dr. Jamie Wagner and Dr. Sheetal Kandiah about the macro- and micro-influences driving antimicrobial costs. They explore how the ACA, pharmacy benefit managers, formulary restrictions, and socioeconomic disparities shape access and prescribing patterns. The discussion highlights real-world challenges for stewardship programs and practical steps to improve affordability and equity in antimicrobial use, with a look ahead at future reforms.
The SHEA Podcast
In this episode of The SHEA Podcast, host Dr. Jonathan Ryder (University of Nebraska Medical Center) speaks with Dr. Aditi Ramakrishnan (Washington University in St. Louis) about how antimicrobial stewardship programs can play a vital role in managing and preventing resistant sexually transmitted infections. They explore the challenges and opportunities at this intersection — from the promise and controversy surrounding doxycycline post-exposure prophylaxis (DoxyPEP), to the debate over routine STI screening among populations on PrEP, and the broader stewardship considerations beyond antibiotic use.
